Guardant Health (GH) EBT Margin (2017 - 2026)
Guardant Health (GH) posted EBT Margin of 35.81% for Q2 2026, up 3.29% sequentially from 37.03% in Q1 2026, and up 722.0% YoY from 4.36% in Q2 2025.
Guardant Health (GH) EBT Margin (2017 - 2026) Analysis & Trends
Guardant Health has reported EBT Margin for 10 years, with the latest figure at 35.81% in Q2 2026.
- Quarterly EBT Margin rose 722.0% year-over-year to 35.81% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 38.41% (up 1138.0% YoY) and the FY2025 annual result came in at 42.52%, up 1636.0% from the prior year.
- EBT Margin climbed to 35.81% in Q2 2026 per GH's latest filing, from 37.03% in the prior quarter.
- Over five years, EBT Margin peaked at 34.91% in Q3 2025 and troughed at 209.8% in Q2 2022.
- A 5-year average of 77.96% and a median of 57.04% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin sank 10395 bps in 2022, then soared 15710 bps in 2023.
- Over 5 years, EBT Margin stood at 109.8% in 2022, then decreased by 10 bps to 120.98% in 2023, then jumped by 55 bps to 54.65% in 2024, then climbed by 15 bps to 46.3% in 2025, then advanced by 23 bps to 35.81% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 35.81%, 37.03%, and 46.3% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.21% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 6.89% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.29% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 28.17% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 10.36% |
| 10 | Guardant Health | 22.38 Bn | 21.33 Bn | 219.03 Mn | -35.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.81% |
| Mar 31, 2026 | -37.03% |
| Dec 31, 2025 | -46.30% |
| Sep 30, 2025 | -34.91% |
| Jun 30, 2025 | -43.03% |
| Mar 31, 2025 | -46.63% |
| Dec 31, 2024 | -54.65% |
| Sep 30, 2024 | -56.26% |
| Jun 30, 2024 | -57.83% |
| Mar 31, 2024 | -68.00% |
| Dec 31, 2023 | -120.98% |
| Sep 30, 2023 | -59.86% |
| Jun 30, 2023 | -52.70% |
| Mar 31, 2023 | -103.56% |
| Dec 31, 2022 | -109.80% |
| Sep 30, 2022 | -137.88% |
| Jun 30, 2022 | -209.80% |
| Mar 31, 2022 | -128.26% |
| Dec 31, 2021 | -66.88% |
| Sep 30, 2021 | -113.35% |